Cargando…
Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929325/ https://www.ncbi.nlm.nih.gov/pubmed/35106934 http://dx.doi.org/10.1002/prp2.918 |
| _version_ | 1784670840605900800 |
|---|---|
| author | Martin, Jennifer H. Head, Richard J. |
| author_facet | Martin, Jennifer H. Head, Richard J. |
| author_sort | Martin, Jennifer H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8929325 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89293252022-03-24 Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology Martin, Jennifer H. Head, Richard J. Pharmacol Res Perspect Editorial John Wiley and Sons Inc. 2022-02-01 /pmc/articles/PMC8929325/ /pubmed/35106934 http://dx.doi.org/10.1002/prp2.918 Text en © 2022 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Martin, Jennifer H. Head, Richard J. Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title | Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title_full | Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title_fullStr | Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title_full_unstemmed | Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title_short | Critical insights to COVID‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| title_sort | critical insights to covid‐19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929325/ https://www.ncbi.nlm.nih.gov/pubmed/35106934 http://dx.doi.org/10.1002/prp2.918 |
| work_keys_str_mv | AT martinjenniferh criticalinsightstocovid19diseaseandpotentialtreatmentsusingasystemsanalysisapproachthatintegratesphysiologypharmacologyandclinicalpharmacology AT headrichardj criticalinsightstocovid19diseaseandpotentialtreatmentsusingasystemsanalysisapproachthatintegratesphysiologypharmacologyandclinicalpharmacology |